Header cover image
  • Investing Ideas
  • Israeli Pharmaceuticals & Biotech Potentially Undervalued Small Caps

Israeli Pharmaceuticals & Biotech Potentially Undervalued Small Caps

Results

1

0 new

Value score of at least 4 focused on companies with a low market cap.

1 companies

InterCure

Market Cap: ₪170.6m

Engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.

INCR

₪3.00

7D

10.0%

1Y

-46.1%